In summary, we hypothesized that exosome-mediated metabolic reprogramming with the HSPA1-GRIN2D/TLR4 axis appeared in HCC, possibly use as a important target for immunotherapy research of HCC. This evidence concerns the gene HSPA1A and hepatocellular carcinoma.